Home › NCT06029062
tACS for Sensory Motor Recovery After Stroke
Recruiting
tACS Brain Neuromodulation for Sensory and Motor Recovery After Neurological Impairments
Who can join
Ages 18 to 75 · All sexes
Full eligibility criteria
Inclusion/exclusion criteria for stroke subjects Inclusion criteria: 1. Age between 18\~75 years old 2. ≥ 6 months post stroke, medically stable; 3. Unilateral, single stroke (no restriction on type (ischemic or hemorrhagic) or volume (large or small) of stroke); 4. Visible finger flexor activation/movement 5. The ability to give consent Exclusion criteria: 1. Patients with visual deficit/neglect; hearing or cognitive impairment; 2. Patients that are currently adjusting tone alternating medications (e.g., baclofen), or 3. Patients received botulinum toxin injection to the arm/fingers \<4 months, or phenol injections \<2 years; 4. Patients with pacemaker, metal implants or supplemental oxygen; 5. Patients who have musculoskeletal disorders, including pain in the affected side 6. Women who are pregnant.
About the study
The overall goal is to investigate the effectiveness of a novel intervention - transcranial alternating current stimulation (tACS) for motor recovery in stroke survivors.
What is being tested
- tACS Sham (device)
- tACS 10Hz (device)
- tACS 20Hz (device)
Sponsor: The University of Texas Health Science Center, Houston · Participants: 14 · Started: Sep 1, 2025
Contact the study team
- Sheng Li, MD, Ph.D · Phone: (713) 797-7125
- Shengai Li, MS · Phone: 713-797-7561
Official record on ClinicalTrials.gov — NCT06029062
Locations in the U.S.
| Texas | The University of Texas Health Science Center, Houston |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.